Partner Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
19 Muzzey St, Lexington, Massachusetts, ...Phone Number
(781) 786-2405Website
www.partnertx.comRevenue
$8.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
2
1
1
1
1
About Partner Therapeutics
Partner Therapeutics (PTx) is a commercial biopharmaceutical company dedicated to enhancing the lives of patients suffering from cancer and other serious diseases. The company focuses on developing innovative treatment options through rigorous scientific research and strong collaborations with the medical and scientific communities. PTx's product offerings include BIZENGRI (zenocutuzumab-zbco) and LEUKINE (sargramostim), aimed at addressing unmet medical needs. Their intended clients primarily include patients with cancer and healthcare professionals involved in oncology and critical care.Explore more
Partner Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Partner Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Partner Therapeutics
Earning: See what the market has to say on Partner Therapeutics recently announced quarterly report
Check out if Partner Therapeutics is spiking on competitors!
Partner Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Partner Therapeutics launches new products
Funding: Get notified immidiatlly once Partner Therapeutics has new funding data
Click to see if Partner Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Partner Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Partner Therapeutics
Find 2 more new buyers
Compare Similar Companies to Partner Therapeutics
Compare insights from companies similar to Partner Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Partner Therapeutics
$8.7M
51-200
Private
<$5M
2017
DR
Debasish RoychowdhuryCo-Founder & Director & Chief Marketing Officer
Company Profile Activity
Activity Insights
Partner Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Partner Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Partner Therapeutics.
Partner Therapeutics financials insights
Gather financial insights about Partner Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$4.8M
Partner Therapeutics Tech Stack
A closer look at the technologies used by Partner Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
John Mulroy has recently been promoted from Senior Vice President, Finance & Treasurer to the role of Chief Financial Officer.
Executive Moves, Promotion
Facilities Relocation / Expansion
Partner Therapeutics is planning to move offices in September 2025. The move will impact approximately 191 employees at the existing office located at 19 Muzzey St, Lexington, MA.
Facilities Relocation/Expansion
Promotion
Executive Move
Partner Therapeutics has announced that Sarah Kurz has been promoted to the role of President & Chief Operating Officer.
Project
Migration, Enterprise Software, Software
Partner Therapeutics News & Media
Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
LEXINGTON, Mass., April 14, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announces the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for BIZENGRI...Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
LEXINGTON, Mass., Feb. 20, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive (NRG1+) non-small...Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma
Designation strengthens BIZENGRI® development program in rare cholangiocarcinoma LEXINGTON, Mass., Feb. 5, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a privately held, fully integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has...Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GI
LEXINGTON, Mass., Jan. 9, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced new data from a post hoc analysis of the eNRGy trial (NCT02912949), evaluating zenocutuzumab in patients with advanced neuregulin 1 fusion-positive...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Partner Therapeutics
Sign Up For FreeTo access detailed company insights
Partner Therapeutics (PTx) is a commercial biopharmaceutical company dedicated to enhancing the lives of patients suffering from cancer and other serious diseases. The company focuses on developing innovative treatment options through rigorous scientific research and strong collaborations with the medical and scientific communities. PTx's product o... Read More
